CD274 and neoplasm: PD-L1 targeting antibodies have proven to be effective whole-body imaging agents translatable into the clinic, however, on-target off-tumor effects, such as PD-L1 staining of epithelial cells or macrophages in distant inflammatory regions, can increase background.